Category

Smartkarma Newswire

TFI International (TFII) Earnings: 2Q Adjusted EPS Surpasses Estimates Despite Revenue Decline

By | Earnings Alerts
“`html

  • TFI International’s adjusted earnings per share (EPS) for the second quarter were $1.34, exceeding estimates of $1.23 but down from $1.71 year-on-year.
  • The company’s revenue was $2.04 billion, representing a 9.9% decline from the previous year, slightly under the estimated $2.06 billion.
  • Truckload revenue saw a decrease of 3.4% year-on-year, totaling $712.3 million.
  • Logistics revenue fell by 11% year-on-year, reaching $393.1 million.
  • LTL (less-than-truckload) revenue was reported at $703.7 million, up from $0.79 million year-on-year.
  • Operating income was $170.2 million, a decline of 18% year-on-year, but it surpassed the estimated $156.7 million.
  • Adjusted EBITDA was $326.6 million, marking a 14% decrease year-on-year, yet it exceeded the estimate of $308.1 million.
  • Adjusted net income stood at $112.0 million, down 23% year-on-year, but above the expected $101.2 million.
  • Alain BΓ©dard, CEO of TFI International, reported strong margin performance and solid free cash flow despite challenging market conditions.
  • Leadership changes have focused teams on revenue quality and operational efficiencies.
  • Analyst recommendations include 14 buys, 5 holds, and 1 sell.

“`


A look at Tfi International Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

TFI International Inc, a key player in the transportation and logistics sector, holds an optimistic long-term outlook based on the Smartkarma Smart Scores. With a solid score of 4 in Momentum, the company is showing promising signs of growth and market traction. Additionally, across the board ratings of 3 in Value, Dividend, Growth, and Resilience indicate a consistently positive performance in key areas. TFI International’s strategic focus on identifying valuable acquisitions and effectively managing its extensive network of subsidiaries positions it well for sustained success in the future.

Operating in the transportation and logistics industry across the United States, Canada, and Mexico, TFI International Inc is strategically positioned for growth and resilience. With a balanced scorecard reflecting stable dividends and strong growth potential, the company’s overall outlook remains steady. The notable momentum score further underscores TFI International’s positive trajectory, pointing towards a prosperous future within the competitive transportation and logistics landscape.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

UFP Industries (UFPI) Earnings: 2Q EPS Falls Short with $1.70, Net Sales Decline 3.5% Amid Market Challenges

By | Earnings Alerts
“`html

  • UFP Industries reported second-quarter earnings per share (EPS) of $1.70, missing both the previous year’s EPS of $2.05 and the estimate of $1.84.
  • The company’s net sales for the quarter were $1.84 billion, a 3.5% decrease from the previous year, and below the expected $1.87 billion.
  • Operating income stood at $123.1 million, representing a 23% decline from the previous year and falling short of the estimated $138.3 million.
  • CEO Will Schwartz commented on the company’s progress, stating they are positioning UFP as a leaner and faster-growing enterprise in anticipation of market recovery.
  • Analyst recommendations include 2 “buys,” 3 “holds,” and no “sells.”

“`


UFP Industries on Smartkarma

Analyst coverage of UFP Industries on Smartkarma reveals valuable insights from Baptista Research. In their report titled “UFP: Will Bold Investments in Deckorators & ProWood Fuel the Next Growth Wave?“, the analysts delve into the company’s fourth-quarter and full-year 2024 financial results. They highlight mixed performance against challenging economic conditions, noting total sales of $6.7 billion and an EBITDA of $682.3 million, reflecting a 10.3% EBITDA margin. Despite a robust balance sheet boasting nearly $1.2 billion in cash, pressures from declining demand across most business segments have impacted pricing and margins.


A look at UFP Industries Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth3
Resilience4
Momentum3
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, UFP Industries is looking at a neutral to positive long-term outlook. With a balanced score of 3 for Value, Dividend, Growth, and Momentum, the company shows stability across these key factors. Moreover, UFP Industries excels in Resilience with a score of 4, indicating a strong ability to weather economic uncertainties. As a holding company in the wood products industry, UFP Industries has a global reach through its subsidiaries, catering to construction and retail sectors.

In summary, UFP Industries, Inc. is positioned with a moderate to strong outlook based on the Smartkarma Smart Scores assessment. With a focus on wood products and serving customers worldwide, the company demonstrates resilience and stability in its financial performance. Investors may find UFP Industries attractive for its consistent performance across various factors despite not scoring exceptionally high in any single category.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Exelixis Inc (EXEL) Earnings: 2Q EPS Surpasses Expectations Despite Revenue Decline

By | Earnings Alerts
  • Exelixis reported an EPS of 65 cents for the second quarter, surpassing the estimate of 57 cents but falling short compared to last year’s 77 cents.
  • Total revenue came in at $568.3 million, a decline of 11% compared to the previous year and below the estimated $578.5 million.
  • Net product revenues rose by 19% year-over-year, totaling $520.0 million, slightly under the estimate of $526.9 million.
  • Total operating expenses were $354.7 million, showing a decrease of 1.8% year-over-year, and fell below the estimated $376.3 million.
  • Research & Development expenses were reduced by 5.1% year-over-year to $200.4 million, also under the estimate of $231.2 million.
  • The company decided not to advance to the phase 3 portion of the STELLAR-305 trial due to emerging competition and potential larger commercial opportunities elsewhere.
  • Analyst ratings include 11 buys, 9 holds, and 1 sell recommendation.

Exelixis Inc on Smartkarma

Analyst coverage of Exelixis Inc on Smartkarma indicates positive sentiment towards the company’s recent financial performance and pipeline expansion. Baptista Research published two research reports on Exelixis Inc, with a bullish outlook on the company’s growth prospects.

In one report titled “Exelixis Inc.: Will It Be Able To Build On the XB628 & Other Pipeline Expansion Opportunities?”, Exelixis demonstrated strong financial performance in the first quarter of 2025, with significant growth in cabozantinib net product revenue. Another report by Baptista Research titled “Exelixis Inc.: Pipeline Expansion & Innovation to Build A Robust Portfolio!” highlighted the company’s robust performance in fiscal year 2024, driven by the strong performance of the cabozantinib franchise and ongoing developments in the oncology portfolio. These analyses provide investors with valuable insights into Exelixis Inc‘s potential for future growth.


A look at Exelixis Inc Smart Scores

FactorScoreMagnitude
Value2
Dividend1
Growth4
Resilience4
Momentum5
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Exelixis Inc, a development-stage biotechnology company focussed on creating small-molecule therapeutics for cancer and other diseases, shows a promising long-term outlook. With strong scores in Growth, Resilience, and Momentum, the company is positioned for future success. Its Growth and Resilience scores indicate a positive trajectory in developing effective pharmaceutical products, while the high Momentum score suggests a current strong performance trend within the industry.

However, the company’s Value and Dividend scores indicate areas for potential improvement. Despite this, the overall outlook for Exelixis Inc seems bright, with a solid foundation for future growth and innovation based on its Smartkarma Smart Scores.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Amkor Technology (AMKR) Earnings Surpass Expectations with Strong 2Q Performance

By | Earnings Alerts
  • Amkor Technology reported second-quarter earnings per share (EPS) of 22 cents, exceeding the analyst estimate of 16 cents.
  • Compared to the previous year, EPS decreased from 27 cents.
  • Net sales for the quarter were $1.51 billion, representing a 3.4% increase year-over-year, and surpassing the estimate of $1.42 billion.
  • The gross margin declined to 12% from 14.5% year-over-year.
  • Adjusted EBITDA came in at $259 million, marking a 4.9% increase year-over-year and exceeding the estimate of $220.3 million.
  • Analyst recommendations for Amkor Technology include 4 buys, 5 holds, and 1 sell.

Amkor Technology on Smartkarma

Independent analysts on Smartkarma, such as Baptista Research, have been providing coverage on Amkor Technology. Baptista Research published reports highlighting the company’s financial performance and market outlook. In one report titled “Amkor Technology: The Advanced Packaging Solutions, Semiconductor Growth & Other Major Drivers!”, Amkor Technology‘s first-quarter financial results for 2025 were discussed. The report mentioned revenue hitting $1.32 billion, meeting the company’s guidance, although earnings per share (EPS) were impacted by increased research and development expenses. The analysts noted that Amkor Technology‘s global manufacturing operations have been relatively unaffected by current tariffs due to their presence in free trade zones.

In another report by Baptista Research, “Amkor Technology: Solid Tailwinds From CHIPS Act & Regulatory Environment Driving Our Bullishness!”, Amkor Technology‘s performance for the fourth quarter and full year 2024 was analyzed. Despite challenges and achievements across different market sectors, the company reported revenues of $1.63 billion for the fourth quarter, with an EPS of $0.43, in line with earlier guidance. However, a 3% revenue decline year-over-year was noted, closing the year at $6.3 billion. The analysts expressed bullishness driven by tailwinds from the CHIPS Act and the regulatory environment, supporting a positive outlook for Amkor Technology.


A look at Amkor Technology Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth3
Resilience4
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Amkor Technology, Inc. provides semiconductor packaging and test services, offering various services from wafer fabrication to final testing. According to Smartkarma Smart Scores, the company receives positive ratings in Value, Resilience, and Momentum, with scores of 4 for Value and Resilience, and 3 for Momentum. This indicates a promising outlook for Amkor Technology in the long term.

With strong scores in key areas like Value, Resilience, and Momentum, Amkor Technology seems well-positioned for future growth and stability in the semiconductor industry. While the company’s Dividend and Growth scores are slightly lower at 3, the overall positive ratings suggest that Amkor Technology is a solid investment choice with a favorable long-term outlook.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

EssilorLuxottica (EL) Earnings: 2Q Revenue Surpasses Estimates with Robust Growth

By | Earnings Alerts
“`html

  • EssilorLuxottica‘s revenue in constant currency grew by 7.3%, surpassing the estimated growth of 5.93%.
  • Total revenue for the second quarter was EU7.18 billion, up 3.2% year-over-year (y/y), meeting expectations.
  • North America revenue slightly increased by 0.2% y/y to EU3.10 billion, exceeding the estimate of EU3.08 billion.
  • EMEA revenue saw a strong increase of 7.9% y/y, reaching EU2.86 billion, slightly above the estimate of EU2.85 billion.
  • Latin America revenue declined by 5.4% y/y, coming in at EU366 million, below the expected EU383.9 million.
  • Asia Pacific revenue grew by 3.4% y/y to EU849 million, but missed the estimate of EU871.8 million.
  • Direct-to-consumer revenue increased by 6.2% y/y, totaling EU3.85 billion, ahead of the estimated EU3.82 billion.
  • Professional Solutions revenue was slightly down by 0.1% y/y at EU3.33 billion, missing the expected EU3.37 billion.
  • First half revenue was EU14.02 billion, marking a 5.5% y/y increase, just short of the EU14.03 billion estimate.
  • Adjusted operating profit for the first half was EU2.53 billion, a 4.2% y/y rise, under the expected EU2.56 billion.
  • Adjusted net income increased by 3% y/y to EU1.80 billion, below the estimate of EU1.84 billion.
  • The adjusted operating margin was 18.3%, aligning with the company’s performance goals.
  • Free cash flow for the period was EU951 million.
  • Sales of AI glasses, Ray-Ban Meta, surged by more than 200% in the first half of the year.
  • EssilorLuxottica confirmed its guidance for future performance.

“`


A look at EssilorLuxottica Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth4
Resilience4
Momentum3
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

EssilorLuxottica, a prominent eyewear manufacturer, holds a favorable long-term outlook based on its Smartkarma Smart Scores. With a promising Growth score of 4 and a resilient score of 4, the company is positioned well for future expansion and to weather potential challenges. This indicates a strong potential for EssilorLuxottica to continue growing steadily and sustainably over time in the highly competitive eyewear market.

Although EssilorLuxottica has average scores in terms of Value and Dividend at 2, its Momentum sits at 3, reflecting a decent level of market momentum. Overall, EssilorLuxottica seems to possess a solid foundation for growth and resilience, which could make it an attractive prospect for investors seeking a balanced investment opportunity in the eyewear industry.

Summary: EssilorLuxottica, a global provider of eyewear products such as sunglasses and lenses, caters to consumers worldwide, positioning itself as a key player in the eyewear market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Rexel SA (RXL) Earnings: 2Q Sales Meet Estimates with Mixed Regional Performance

By | Earnings Alerts
  • Rexel’s second-quarter sales totaled €4.95 billion, slightly above the estimate of €4.92 billion.
  • In Europe, sales were €2.39 billion, down 2.4% from the previous year, and slightly below the estimated €2.41 billion.
  • North America saw a strong performance, with sales of €2.28 billion marking a 7.3% increase year-over-year, surpassing the estimate of €2.21 billion.
  • The Asia Pacific region reported a significant decline in revenue to €277.3 million, a 19% decrease from the previous year, missing the estimate of €295.5 million.
  • Overall same-day sales grew by 1.8%, exceeding the forecasted growth of 1.58%.
  • Europe’s same-day sales fell by 3%, against an estimated decline of 1.34%.
  • North America’s same-day sales increased by 8.7%, outperforming the expected growth of 4.98%.
  • Asia Pacific experienced a decrease in same-day sales by 6.5%, missing the expected increase of 2.44%.
  • The first half of the year saw adjusted EBITA of €563.5 million, which was below the estimated €571.3 million.
  • The adjusted EBITA margin was reported at 5.8%.
  • Adjusted free cash flow for the first half was €127.2 million, marking a 62% decrease year-over-year.
  • Rexel maintains its 2025 outlook, expecting an adjusted EBITA margin of around 6%.

Rexel SA on Smartkarma

On Smartkarma, analyst coverage of Rexel SA is gaining attention with Baptista Research‘s recent report titled “Rexel: Initiation of Coverage.” The report dives into Rexel, a global leader in electrical supplies distribution, and its full-year results for 2024. The analyst highlights the company’s challenges and progress during a complex year, encapsulating key elements of the earnings call to offer a balanced view of Rexel’s current performance and future prospects. Despite facing a 2.4% decline in like-for-like sales growth in 2024, aligning with revised guidance, the report acknowledges the impact of a softer economic environment, especially in Europe.


A look at Rexel SA Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth2
Resilience3
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Rexel SA, a company that distributes low voltage electrical equipment, shows a promising long-term outlook. With strong scores in Dividend (4) and Momentum (4), the company is positioned well for future growth and income generation. These scores indicate that Rexel is likely to provide good returns to its investors through dividends and has positive momentum in its business activities, reflecting potential for growth.

Although the scores for Value, Growth, and Resilience are slightly lower, at 3, 2, and 3 respectively, they still suggest a decent overall performance. The company’s resilience score of 3 indicates a moderate ability to weather economic uncertainties. With a diversified product range catering to various customer segments, including electrical contractors, industrial companies, and homeowners, Rexel SA appears to have a stable foundation for sustained growth in the long term.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Fomento Economico Mexica-Ubd (FEMSAUBD) Earnings: 2Q Revenue Meets Estimates Amid Diverse Division Performance

By | Earnings Alerts
  • Femsa’s second-quarter revenue reached MXN211.36 billion, marking a 6.3% year-over-year increase and aligning with estimates of MXN211.3 billion.
  • Health Division’s revenue surged by 16% year-over-year to MXN21.85 billion, slightly exceeding the estimate of MXN21.84 billion.
  • Fuel Division’s revenue saw a marginal increase of 0.6% year-over-year, totaling MXN17.10 billion, slightly below the estimate of MXN17.37 billion.
  • Net income dropped significantly by 64% year-over-year to MXN5.59 billion.
  • Basic earnings per share (EPS) was recorded at MXN0.13.
  • Gross profit stood at MXN85.92 billion, up by 4.2% year-over-year, but missed the estimate of MXN87.92 billion.
  • Health Division’s gross profit increased by 14% year-over-year, reaching MXN6.50 billion, which is below the estimate of MXN6.67 billion.
  • Fuel Division’s gross profit rose by 6.6% year-over-year to MXN2.15 billion, exceeding the estimate of MXN2 billion.
  • Operating income grew by 1.2% year-over-year to MXN17.83 billion, falling short of the estimated MXN18.21 billion.
  • Gross margin decreased to 40.7% from 41.5% year-over-year, slightly below the estimated 41.1%.
  • Health Division same-store sales experienced a strong growth of 13.1%.
  • Fuel Division same-store sales increased by 4.9%.
  • Analyst recommendations include 11 buys, 4 holds, and no sells.

Fomento Economico Mexica-Ubd on Smartkarma

Analyst coverage of Fomento Economico Mexica-Ubd on Smartkarma has been positive, with Actinver Research providing insightful reports on the company’s performance. In their report titled “Fomento Economico Mexica-UbdActinver Research – FEMSA 1Q25: Proximity starts soft (Quick View)”, Actinver highlights that sales were 11.1% higher YoY, exceeding estimates and staying in line with consensus. Although there were challenges like a soft consumer environment and declining YoY traffic, management anticipates an improvement in momentum from 3Q25 onwards.

Another report by Actinver, “Fomento Economico Mexica-UbdActinver Research – FEMSA 4Q24: Better than expected (Quick View)”, notes a 12.8% YoY sales growth, surpassing estimates driven by various factors including strong segment growth and inorganic expansion. Despite a decline in traffic for the third consecutive quarter, SSS at Proximity Americas increased to 3.8%. The analysts at Actinver maintain a bullish sentiment on Fomento Economico Mexica-Ubd based on their research findings.


A look at Fomento Economico Mexica-Ubd Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth3
Resilience3
Momentum2
OVERALL SMART SCORE2.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Fomento Economico Mexicano-Ubd has a well-rounded outlook for the long term. With consistent scores of 3 across Value, Dividend, Growth, and Resilience, the company demonstrates stability and potential for growth. While the Momentum score lags slightly behind at 2, overall, Fomento Economico Mexicano-Ubd appears to have a positive trajectory.

Fomento Economico Mexicano-Ubd, a company operating within the Coca-Cola system producing non-alcoholic beverages in Latin America, shows promise with its balanced Smart Scores. With a diversified portfolio that includes convenience stores in Mexico and Colombia and a stake in Heineken, FEMSA has established itself as a resilient player in the market. Investors may find Fomento Economico Mexicano-Ubd to be a reliable option for long-term investment.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Gail India (GAIL) Earnings: 1Q Net Income Falls Short of Estimates, Sees 31% Year-on-Year Decline

By | Earnings Alerts
  • GAIL India’s net income for the first quarter of 2025 fell by 31% year-over-year, amounting to 18.9 billion rupees, missing analysts’ estimates of 20.49 billion rupees.
  • The company’s revenue increased by 3.3% compared to the previous year, reaching 347.9 billion rupees, but still fell short of the expected 358.83 billion rupees.
  • Total costs for the quarter rose by 7% year-over-year, totaling 325.5 billion rupees.
  • Other income decreased by 22% from the previous year, totaling 2.92 billion rupees.
  • Current analyst ratings on GAIL India include 28 buys, 5 holds, and 2 sells.

A look at Gail India Smart Scores

FactorScoreMagnitude
Value4
Dividend5
Growth3
Resilience3
Momentum2
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, GAIL India Limited shows a promising long-term outlook. With a strong dividend score of 5, investors can expect good returns in the form of dividends over time. The company also scores well in value at 4, indicating that it might be undervalued in the market. However, the growth score of 3 suggests that while there is potential for expansion, it may not be as high as some other factors. Additionally, GAIL India scores decently in resilience and momentum at 3 and 2 respectively, showing stability and room for improvement in market performance.

GAIL India Limited, a Government of India undertaking, primarily deals with natural gas and liquefied petroleum gas processing and distribution. Considering its high dividend score, strong value, and decent resilience, GAIL India seems poised for stable growth in the long term. While the momentum score is relatively lower, the overall outlook remains positive, offering investors a potentially profitable opportunity in the energy sector.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Torrent Pharmaceuticals (TRP) Earnings: Q1 Revenue Aligns with Estimates Amid Varying Regional Sales Performance

By | Earnings Alerts
  • Torrent Pharma’s first-quarter revenue was 31.78 billion rupees, closely matching the estimated 31.63 billion rupees.
  • Domestic sales came in slightly below expectations at 18.11 billion rupees, compared to the estimate of 18.38 billion rupees.
  • US revenue outperformed estimates, reaching 3.08 billion rupees against the projected 2.91 billion rupees.
  • Brazilian market revenue was slightly below the expected figure, at 2.18 billion rupees compared to an estimate of 2.27 billion rupees.
  • Revenue from Germany met the market forecast, recording 3.08 billion rupees against an estimate of 3.1 billion rupees.
  • Research and development expenses were lower than anticipated, amounting to 1.57 billion rupees versus the estimated 1.65 billion rupees.
  • Analyst recommendations include 19 buys, 10 holds, and 3 sells for Torrent Pharma.

Torrent Pharmaceuticals on Smartkarma

Analysts on Smartkarma, such as Nimish Maheshwari and Tina Banerjee, are bullish on Torrent Pharmaceuticals. Nimish Maheshwari‘s report covers Torrent’s acquisition of JB Chemicals for INR 25,689 crore, marking the second-largest pharma deal in Indian history. This move is set to boost Torrent’s market share, expand its presence in the CDMO sector, and drive revenue growth both domestically and internationally.

Tina Banerjee‘s analysis focuses on Torrent Pharmaceuticals‘ strong Q4FY25 results, showing an 11% YoY increase in net profit and 8% YoY revenue growth driven by the domestic business performance and margin expansion. The company’s performance in the Indian market is particularly highlighted, with revenue growth driven by focus therapies and new launches. With positive trends in the U.S. and Brazil markets, Torrent Pharmaceuticals seems to be on a path towards sustained growth and margin improvement.


A look at Torrent Pharmaceuticals Smart Scores

FactorScoreMagnitude
Value2
Dividend4
Growth4
Resilience4
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on Smartkarma Smart Scores, Torrent Pharmaceuticals is exhibiting a promising long-term outlook. With high scores in Dividend, Growth, Resilience, and Momentum, the company appears to be well-positioned for success in the pharmaceutical industry. Torrent Pharmaceuticals is known for manufacturing bulk drugs and pharmaceutical formulations, including a range of drugs like cardio-vascular, psychotropic, and anti-biotic medications. Additionally, its presence in various international markets through wholly owned subsidiaries provides further opportunities for growth and expansion.

Investors looking at Torrent Pharmaceuticals may find its overall outlook appealing due to its solid scores in key factors essential for long-term success. The company’s focus on delivering dividends, strong growth potential, resilience, and positive momentum in the market highlight its stability and growth prospects. With a diverse product portfolio and a global presence, Torrent Pharmaceuticals seems to be on a path towards sustained growth and value creation for its stakeholders.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Singapore Airlines (SIA) Earnings: 1Q Net Income Drops 59% to S$186.1M Amid Rising Fuel Costs

By | Earnings Alerts
  • Singapore Airlines reported net income of S$186.1 million for the first quarter of 2025, a decrease of 59% compared to S$451.7 million the previous year.
  • The operating profit stood at S$404.5 million, marking a 14% decline year-over-year.
  • Fuel costs amounted to S$1.26 billion, showing a 7.9% reduction from the prior year.
  • There was a fuel hedging loss of S$60 million.
  • Basic earnings per share (EPS) fell to S$0.063 compared to S$0.128 the year before.
  • Passenger load factor improved slightly, with the group airlines at 87.6%, up from 86.9% last year.
  • Scoot, a subsidiary of Singapore Airlines, achieved a passenger load factor of 91.5%, an increase from 89% year-over-year.
  • Singapore Airlines observed a 3.5% decrease in passenger yield per kilometer to S$0.110.
  • Available seat kilometers increased by 4.2% to 35.03 billion.
  • Revenue Passenger Kilometers (RPK) rose by 4.1%, reaching 38.76 billion.
  • Total revenue for the quarter grew slightly by 1.5% to S$4.79 billion.
  • Singapore Airlines noted that demand for air travel remains healthy in the second quarter.
  • Uncertain demand in the cargo sector is attributed to ongoing tariffs, and the group plans to continue adapting its capacity.
  • The decline in net profit is mainly due to reduced interest income resulting from lower cash balances and interest rate cuts.
  • The company faced losses from associated companies, notably Air India, whose financial results were included this year.
  • Analyst recommendations include 3 buys, 7 holds, and 4 sells.

Singapore Airlines on Smartkarma

Analyst coverage on Singapore Airlines by Henry Soediarko on Smartkarma highlights concerns over the impact of higher crude oil prices on the company’s earnings. In the report titled “Singapore Airlines (SIA): Losing from Higher Crude Oil Price,” Soediarko points out that the airline faces potential earnings pressure due to the Middle East crisis and the rising cost of crude oil. With significant exposure to oil prices, Singapore Airlines may see a decline in earnings as high as 30% of total costs. Despite this bearish outlook, the company’s elevated dividend yield could offer some support in the short term.


A look at Singapore Airlines Smart Scores

FactorScoreMagnitude
Value3
Dividend5
Growth4
Resilience4
Momentum4
OVERALL SMART SCORE4.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Singapore Airlines Limited, a prominent player in the aviation industry, is positioned well for long-term success according to Smartkarma Smart Scores. With a strong focus on providing value-driven services and a commendable dividend payout, the company’s financial health is reflected in its high scores of 3 for Value and a perfect 5 for Dividend. Additionally, with solid scores of 4 for Growth, Resilience, and Momentum, Singapore Airlines showcases a robust performance across various key factors, indicating a promising outlook for the future.

As a leader in air transportation services covering multiple regions globally, Singapore Airlines leverages its expertise in engineering, pilot training, air charter, and tour wholesaling. With a strategic approach to growth, resilience in challenging market conditions, and positive momentum driving its operations, Singapore Airlines is well-positioned to navigate the dynamic landscape of the aviation industry effectively. Investors looking for a company with a strong overall outlook based on Smartkarma Smart Scores can find confidence in the long-term prospects of Singapore Airlines as it continues to expand and innovate in the competitive aviation sector.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars